Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood : a prospective cohort study

Ghalwash, Mohamed ; Anand, Vibha ; Lou, Olivia ; Martin, Frank ; Rewers, Marian ; Ziegler, Anette G. ; Toppari, Jorma ; Hagopian, William A. and Veijola, Riitta LU (2023) In The Lancet Child and Adolescent Health 7(4). p.261-268
Abstract

Background: Screening for islet autoantibodies in children and adolescents identifies individuals who will later develop type 1 diabetes, allowing patient and family education to prevent diabetic ketoacidosis at onset and to enable consideration of preventive therapies. We aimed to assess whether islet autoantibody screening is effective for predicting type 1 diabetes in adolescents aged 10−18 years with an increased risk of developing type 1 diabetes. Methods: Data were harmonised from prospective studies from Finland (the Diabetes Prediction and Prevention study), Germany (the BABYDIAB study), and the USA (Diabetes Autoimmunity Study in the Young and the Diabetes Evaluation in Washington study). Autoantibodies against insulin,... (More)

Background: Screening for islet autoantibodies in children and adolescents identifies individuals who will later develop type 1 diabetes, allowing patient and family education to prevent diabetic ketoacidosis at onset and to enable consideration of preventive therapies. We aimed to assess whether islet autoantibody screening is effective for predicting type 1 diabetes in adolescents aged 10−18 years with an increased risk of developing type 1 diabetes. Methods: Data were harmonised from prospective studies from Finland (the Diabetes Prediction and Prevention study), Germany (the BABYDIAB study), and the USA (Diabetes Autoimmunity Study in the Young and the Diabetes Evaluation in Washington study). Autoantibodies against insulin, glutamic acid decarboxylase, and insulinoma-associated protein 2 were measured at each follow-up visit. Children who were lost to follow-up or diagnosed with type 1 diabetes before 10 years of age were excluded. Inverse probability censoring weighting was used to include data from remaining participants. Sensitivity and the positive predictive value of these autoantibodies, tested at one or two ages, to predict type 1 diabetes by the age of 18 years were the main outcomes. Findings: Of 20 303 children with an increased type 1 diabetes risk, 8682 were included for the analysis with inverse probability censoring weighting. 1890 were followed up to 18 years of age or developed type 1 diabetes between the ages of 10 years and 18 years, and their median follow-up was 18·3 years (IQR 14·5–20·3). 442 (23·4%) of 1890 adolescents were positive for at least one islet autoantibody, and 262 (13·9%) developed type 1 diabetes. Time from seroconversion to diabetes diagnosis increased by 0·64 years (95% CI 0·34–0·95) for each 1-year increment of diagnosis age (Pearson's correlation coefficient 0·88, 95% CI 0·50–0·97, p=0·0020). The median interval between the last prediagnostic sample and diagnosis was 0·3 years (IQR 0·1–1·3) in the 227 participants who were autoantibody positive and 6·8 years (1·6–9·9) for the 35 who were autoantibody negative. Single screening at the age of 10 years was 90% (95% CI 86–95) sensitive, with a positive predictive value of 66% (60–72) for clinical diabetes. Screening at two ages (10 years and 14 years) increased sensitivity to 93% (95% CI 89–97) but lowered the positive predictive value to 55% (49–60). Interpretation: Screening of adolescents at risk for type 1 diabetes only once at 10 years of age for islet autoantibodies was highly effective to detect type 1 diabetes by the age of 18 years, which in turn could enable prevention of diabetic ketoacidosis and participation in secondary prevention trials. Funding: JDRF International.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
contributor
Achenbach, Peter ; Bonifacio, Ezio ; Crouch, Claire ; Dunne, Jessica ; LU ; Frohnert, Brigitte I. ; Hu, Jianying ; Hyöty, Heikki ; Ilonen, Jorma ; Jönsson, Josefin ; Killian, Michael ; Knip, Mikael ; Koski, Eileen ; Li, Ying ; Li, Zhiguo ; Liu, Bin ; LU ; Malhotra, Ashwani ; LU ; Meyer, Jocelyn ; Moore, Shelley ; Ng, Kenney ; Norris, Jill ; Roy, Shreya ; LU ; Steck, Andrea ; Stavropoulos, Harry ; Waugh, Kathleen ; Winkler, Christiane ; Yu, Liping and LU orcid
author collaboration
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
The Lancet Child and Adolescent Health
volume
7
issue
4
pages
8 pages
publisher
Elsevier
external identifiers
  • scopus:85149643588
  • pmid:36681087
ISSN
2352-4642
DOI
10.1016/S2352-4642(22)00350-9
language
English
LU publication?
yes
additional info
Funding Information: We thank the participating children and families, and the personnel of the study sites. This work was supported by funding from JDRF (IBM: 1-RSC-2017-368-I-X, 1-IND-2019-717-I-X, DAISY: 1-SRA-2019-722-I-X, 1-RSC-2017-517-I-X, 5-ECR-2017-388-A-N, DIPP: 1-RSC-2018-555-I-X, 1-SRA-2019-721-I-X, and DEW-IT: 1-SRA-2019-719-I-X, 1-RSC-2017-516-I-X).
id
f1b3503d-5c9a-416c-bcdb-50590ddcc77b
date added to LUP
2023-03-24 09:42:52
date last changed
2024-07-11 07:18:41
@article{f1b3503d-5c9a-416c-bcdb-50590ddcc77b,
  abstract     = {{<p>Background: Screening for islet autoantibodies in children and adolescents identifies individuals who will later develop type 1 diabetes, allowing patient and family education to prevent diabetic ketoacidosis at onset and to enable consideration of preventive therapies. We aimed to assess whether islet autoantibody screening is effective for predicting type 1 diabetes in adolescents aged 10−18 years with an increased risk of developing type 1 diabetes. Methods: Data were harmonised from prospective studies from Finland (the Diabetes Prediction and Prevention study), Germany (the BABYDIAB study), and the USA (Diabetes Autoimmunity Study in the Young and the Diabetes Evaluation in Washington study). Autoantibodies against insulin, glutamic acid decarboxylase, and insulinoma-associated protein 2 were measured at each follow-up visit. Children who were lost to follow-up or diagnosed with type 1 diabetes before 10 years of age were excluded. Inverse probability censoring weighting was used to include data from remaining participants. Sensitivity and the positive predictive value of these autoantibodies, tested at one or two ages, to predict type 1 diabetes by the age of 18 years were the main outcomes. Findings: Of 20 303 children with an increased type 1 diabetes risk, 8682 were included for the analysis with inverse probability censoring weighting. 1890 were followed up to 18 years of age or developed type 1 diabetes between the ages of 10 years and 18 years, and their median follow-up was 18·3 years (IQR 14·5–20·3). 442 (23·4%) of 1890 adolescents were positive for at least one islet autoantibody, and 262 (13·9%) developed type 1 diabetes. Time from seroconversion to diabetes diagnosis increased by 0·64 years (95% CI 0·34–0·95) for each 1-year increment of diagnosis age (Pearson's correlation coefficient 0·88, 95% CI 0·50–0·97, p=0·0020). The median interval between the last prediagnostic sample and diagnosis was 0·3 years (IQR 0·1–1·3) in the 227 participants who were autoantibody positive and 6·8 years (1·6–9·9) for the 35 who were autoantibody negative. Single screening at the age of 10 years was 90% (95% CI 86–95) sensitive, with a positive predictive value of 66% (60–72) for clinical diabetes. Screening at two ages (10 years and 14 years) increased sensitivity to 93% (95% CI 89–97) but lowered the positive predictive value to 55% (49–60). Interpretation: Screening of adolescents at risk for type 1 diabetes only once at 10 years of age for islet autoantibodies was highly effective to detect type 1 diabetes by the age of 18 years, which in turn could enable prevention of diabetic ketoacidosis and participation in secondary prevention trials. Funding: JDRF International.</p>}},
  author       = {{Ghalwash, Mohamed and Anand, Vibha and Lou, Olivia and Martin, Frank and Rewers, Marian and Ziegler, Anette G. and Toppari, Jorma and Hagopian, William A. and Veijola, Riitta}},
  issn         = {{2352-4642}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{261--268}},
  publisher    = {{Elsevier}},
  series       = {{The Lancet Child and Adolescent Health}},
  title        = {{Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood : a prospective cohort study}},
  url          = {{http://dx.doi.org/10.1016/S2352-4642(22)00350-9}},
  doi          = {{10.1016/S2352-4642(22)00350-9}},
  volume       = {{7}},
  year         = {{2023}},
}